Gaucher's Disease Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Clinical Trials

Phase 1/2 Clinical Trial of PR001 in Infants With Type 2 Gaucher Disease (PROVIDE)
Condition:   Gaucher Disease, Type 2 Intervention:   Biological: PR001 Sponsor:   Prevail Therapeutics Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 2, 2020 Category: Research Source Type: clinical trials

Phase 1/2 Lentiviral Vector Gene Therapy AVR-RD-02 for Subjects With Type 1 Gaucher Disease
Condition:   Gaucher Disease Intervention:   Drug: AVR-RD-02 Sponsor:   AvroBio Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 30, 2019 Category: Research Source Type: clinical trials

Phase 1/2 Safety & Efficacy Study, Lentiviral Vector Gene Therapy AVR-RD-02 for Subjects With Type 1 Gaucher Disease
Condition:   Gaucher Disease Intervention:   Drug: AVR-RD-02 Sponsor:   AvroBio Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 30, 2019 Category: Research Source Type: clinical trials

Phase 1/2 Lentiviral Vector Gene Therapy AVR-RD-02 for Subjects With Type 1 Gaucher Disease
Condition:   Gaucher Disease Intervention:   Drug: AVR-RD-02 Sponsor:   AvroBio Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 30, 2019 Category: Research Source Type: clinical trials